Stephen T. Worland - 15 May 2023 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Issuer symbol
EFTR on OTC
Transactions as of
15 May 2023
Net transactions value
+$2,938
Form type
4
Filing time
16 May 2023, 08:03:52 UTC
Previous filing
21 Apr 2023
Next filing
14 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $2,938 +6,401 +2.9% $0.4590 227,426 15 May 2023 Direct F1
holding EFTR Common Stock 562,339 15 May 2023 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.